Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01346319 · ClinicalTrials.gov registry record · Phase 1
Study of the Safety, Tolerability and Pharmacokinetics of Testosterone Undecanoate in Hypogonadal Males.
A Phase 1 study of Hypogonadal Males, sponsored by Abbott.
- Completed
- Registry status
- Phase 1
- Development phase
- 1
- Study location
NCT01346319 is a Phase 1 study of Hypogonadal Males that has completed, run by Abbott. The trial reports 1 study location across 1 state.
The verdict
NCT01346319, a Phase 1 study of Hypogonadal Males, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 1
- Study location
Study Summary
Phase 1 Dose Escalating Study of the safety, tolerability and pharmacokinetics of testosterone in hypogonadal males.
Conditions Studied
Interventions
- DRUG placebo
- DRUG ABT-SLV361
Study Locations (1)
Florida
- Site Reference ID/Investigator# 51964 - Fort Myers
Trial Details
| Field | Value |
|---|---|
| Start Date | 2011-04 |
| Est. Completion | 2011-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01346319
The ClinicalTrials.gov registry entry for NCT01346319 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypogonadal Males appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT01346319 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT01346319 about?
NCT01346319 is a clinical study titled "Study of the Safety, Tolerability and Pharmacokinetics of Testosterone Undecanoate in Hypogonadal Males.". Phase 1 Dose Escalating Study of the safety, tolerability and pharmacokinetics of testosterone in hypogonadal males.
What is the current status of trial NCT01346319?
This trial is currently completed. It is a Phase 1 study. The study started on 2011-04. Estimated completion is 2011-09.
What conditions does trial NCT01346319 study?
This clinical trial studies the following conditions: Hypogonadal Males.
What interventions are being tested in trial NCT01346319?
The interventions under investigation include: placebo (DRUG), ABT-SLV361 (DRUG).
Who is sponsoring clinical trial NCT01346319?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01346319 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypogonadal Males
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.